SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-016473
Filing Date
2023-10-17
Accepted
2023-10-17 07:33:09
Documents
14
Period of Report
2023-10-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K olma-20231013x8k.htm   iXBRL 8-K 42274
2 EX-99.1 olma-20231013xex99d1.htm EX-99.1 11334
3 GRAPHIC olma-20231013xex99d1002.jpg GRAPHIC 7606
  Complete submission text file 0001558370-23-016473.txt   187192

Data Files

Seq Description Document Type Size
4 EX-101.SCH olma-20231013.xsd EX-101.SCH 3125
5 EX-101.LAB olma-20231013_lab.xml EX-101.LAB 15271
6 EX-101.PRE olma-20231013_pre.xml EX-101.PRE 9659
8 EXTRACTED XBRL INSTANCE DOCUMENT olma-20231013x8k_htm.xml XML 4727
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39712 | Film No.: 231328452
SIC: 2834 Pharmaceutical Preparations